Cocrystal Pharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Bothell, WA
COCP chart
What traders are saying about $COCP
Latest postsCocrystal Pharma, Inc. news
- Cocrystal Pharma, Inc. Estimates – NASDAQ:COCP
TradingView ·
- This Beaten Down Biotech Stock Has A Secret Billionaire Backer Ncis Sydney (nGext5ndB4)
Unisba Media ·
- A norovirus breakthrough?; another women’s healthtech haul
pharmavoice.com ·
- Cocrystal Pharma’s new CEO hopes to crack the norovirus code
pharmavoice.com ·
- Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
Yahoo Finance ·
- Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Yahoo Finance ·
- COCP: $5 Million Private Placement with OPKO Health
Yahoo Finance ·
- Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
Yahoo Finance ·
- Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Yahoo Finance ·
- Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
Yahoo Finance ·
- COCP: Presentation Highlights CDI-988
Yahoo Finance ·
- Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
Yahoo Finance ·
Cocrystal Pharma, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$8.8M | -$17.5M | -$18.0M | -$38.8M |
| Diluted EPS | $-0.78 | $-1.72 | $-1.87 | $-4.77 |
| Total assets (year end) | $9.7M | $13.5M | $31.3M | $40.8M |
| Cash and equivalents (year end) | $7.0M | $9.9M | $26.4M | $37.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cocrystal Pharma, Inc.
- Ticker
- COCP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bothell, WA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1412486
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
Frequently asked questions
What exchange is Cocrystal Pharma, Inc. listed on?
Cocrystal Pharma, Inc. trades on the Nasdaq under the ticker symbol COCP.
What industry is Cocrystal Pharma, Inc. in?
Cocrystal Pharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Cocrystal Pharma, Inc. headquartered?
Cocrystal Pharma, Inc.'s business address on file with the SEC is in Bothell, WA.
When does Cocrystal Pharma, Inc.'s fiscal year end?
Cocrystal Pharma, Inc.'s fiscal year ends on December 31.
How much revenue did Cocrystal Pharma, Inc. report?
Cocrystal Pharma, Inc. reported $2.0M in revenue for calendar year 2020, according to its SEC filings.